Dissecting the impact of target-binding kinetics of protein binders on tumor localization

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Controlling in vivo behavior of protein therapeutics is crucial for improving clinical outcomes.
• Modulating biochemical properties like binding affinity can enhance therapeutic effects.
• The relationship between binding affinity and tumor localization is not well-established.

Purpose of the Study:

• To investigate the influence of protein binding affinity on tumor localization.
• To understand how binding kinetics affect the accumulation of protein binders in tumors.

Main Methods:

• Utilized four repeatbodies with varying affinities to epidermal growth factor receptor (EGFR).
• Employed biochemical analysis and molecular imaging techniques.
• Assessed the binding and dissociation kinetics of repeatbodies in relation to tumor targeting.

Main Results:

• Demonstrated that optimal binding affinity, balancing target binding and dissociation, facilitates deep tumor penetration.
• Showed that such optimal affinity enhances the accumulation of protein binders within tumors.
• Overcame the binding-site-barrier effect through tailored binding kinetics.

Conclusions:

• Binding kinetics-based protein design is a viable strategy for developing effective protein therapeutics.
• Fine-tuned protein binders with optimal affinity can improve tumor localization and accumulation.
• This approach holds promise for advancing cancer therapy development.